| AAV | Adeno-associated virus |
| ASO | Antisense oligonucleotide |
| CNS | Central nervous system |
| CELF1 | CUGBP Elav-Like Family Member 1 |
| CRISPR | Clustered regularly interspaced short palindromic repeat |
| DM | Myotonic dystrophy |
| DM1 | Myotonic dystrophy type1 |
| DM2 | Myotonic dystrophy type 2 |
| DMD | Duchenne muscular dystrophy |
| FXS | Fragile X syndrome |
| GalNac | N-acetyl-D-galactosamine |
| HD | Huntington disease |
| KO | Knockout |
| LNA | Locked nucleic acid |
| MBNL | Muscle blind-like proteins |
| miRNA | MicroRNA |
| 2′-MOE | 2′-O-methoxyethyl |
| mRNA | Messenger RNA |
| nPTB | Polypyrimidine tract-binding protein |
| PLGA | poly(lactide-co-glycolide) |
| PS | Phosphorothioate |
| RISC | RNA-induced silencing complex |
| RNAi | RNA interference |
| SCAs | Spinocerebellar ataxias |
| SCA8 | Spinocerebellar ataxia type 8 |